Zadaxin ( DrugBank: - )

2 diseases

ID	Disease name (Link within this page)	Number of trials
65	Primary immunodeficiency	1
299	Cystic fibrosis	1

65. Primary immunodeficiency

Clinical trials : 482 / Drugs : 653 - (DrugBank : 119) / Drug target genes : 92 - Drug target pathways : 212

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2021-003327-15-NL (EUCTR)	21/02/2022	19/01/2022	Thymosin-a1 in immunodeficiency associated mood disorders	An open-label, 8-week, proof of concept trial on thymosin-a1 (thymalfasin) in the treatment of prima ...	Primary immunodeficiency;Therapeutic area: Diseases [C] - Immune System Diseases [C20]	Trade Name: Thymalfasin Product Name: Thymafalsin INN or Proposed INN: THYMALFASIN Other descriptive na ...	Erasmus MC	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	20	Phase 2	Netherlands

Clinical trials : 1,696 / Drugs : 1,644 - (DrugBank : 272) / Drug target genes : 96 - Drug target pathways : 170

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2019-001441-40-IT (EUCTR)	17/12/2019	24/05/2021	Study of the use of the drug Thymosin alpha 1 in adults patients with Cystic Fibrosis.	A phase II trial to assess the activity and tolerability of Thymosin alpha 1 in Cystic Fibrosis Pati ...	Cystic Fibrosis MedDRA version: 20.0;Level: PT;Classification code 10011762;Term: Cystic fibrosis;Sy ...	Product Name: Zadaxin Product Code: [Ta1] Other descriptive name: Thymosin alpha 1	SciClone Pharmaceuticals Limited Ltd	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	24	Phase 2	Italy